Back to mobile site

UBS Reiterates Buy Rating on Eli Lilly (LLY)

June 12, 2025 10:38 AM EDT Send to a Friend
UBS analyst Trung Huynh reiterated a Buy rating and $1,050.00 price target on Eli Lilly (NYSE: LLY).The analyst commented, "LLY's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login